News

Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

June 27, 2013
The organization’s board created the holding company in 2012 to oversee and support its main business units, which include STBTC, QualTex Laboratories and GenCure, as well as the Blood and Tissue Center Foundation.
October 23, 2012

SAN ANTONIO - The South Texas Blood & Tissue Center (STBTC), through its GenCure affiliate, has established a research collaboration agreement with San Antonio-based StemBioSys, Inc. to provide mononuclear cells from clinical grade human umbilical cord blood (hUCB) to StemBioSys for research and development use.

StemBioSys will utilize the hUCB stem cells to further evaluate the use of its patented extracellular matrix technology for the isolation and expansion of a rare subset of stem cells found in hUCB. Previous research performed by StemBioSys co-founder Dr. Xiao-Dong Chen has indicated that these cells contain properties indicative of a primordial stem cell population with a broad range of potential use in stem cell research, drug development and therapeutic applications.

September 17, 2012

SAN ANTONIO – In September 2011, five-year-old Nolan Naranjo from San Benito, TX, was diagnosed with severe aplastic anemia, a bone marrow disease that puts patients at risk for life-threatening infections or bleeding.* After months of failed treatment, Naranjo has turned to the Be The Match marrow registry to find a lifesaving donor. To help find his match, the South Texas Blood & Tissue Center (STBTC) is partnering with the Bexar County Sheriff’s Office and the Hispanic American Police Command Officers Association (HAPCOA) to host an employee marrow registration.

WHAT:            Bexar County Sheriff’s Office Marrow Registration
WHEN:            Wednesday, Sept. 19
                         7am – 7pm (media interviews from 10am – 11am)
WHERE:          Bexar County Adult Detention Center – In the GetAway Café
                         200 N. Comal, San Antonio, TX 78207

April 24, 2012

SAN ANTONIO – A little more than a year after receiving a transplant that saved her life, Shannon Dean Turci will meet Zach Moore- the gentleman who donated peripheral blood stem cells that gave her a second chance. Shannon and Zach will meet in person for the first time Tuesday, April 24th at 7:30pm during Be The Match Central Regional Meeting at Hotel Contessa located at 306 West Market Street.

 A little more than a year after receiving a transplant that saved her life, Shannon Dean Turci will meet Zach Moore- the gentleman who donated peripheral blood stem cells that gave her a second chance. Shannon and Zach will meet in person for the first time Tuesday, April 24 at 7:30pm during Be The Match Central Regional Meeting at Hotel Contessa located at 306 West Market Street.

Cord blood units also studied for use in diabetes research
February 27, 2012

SAN ANTONIO – The Texas Cord Blood Bank today announced it has reached the milestone of banking more than 10,000 units of life-saving umbilical cord blood for the statewide repository.

The Texas Cord Blood Bank has been able to provide more than 1,000 cord blood units for transplant and research. One example is the use of cord blood by renowned pediatric hematologist-oncologist Dr. Joel Weinthal director of the Stem Cell Transplant and medical director of the Apheresis Program at Medical City Hospital in Dallas.

Pages